share_log

Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY

Reneo Pharmaceuticals Q3 EPS $(0.53) Down From $(0.52) YoY

Reneo PharmPharmticals第三季度每股收益為0.53美元,較上年同期下降0.52美元
Benzinga Real-time News ·  2022/11/08 07:43

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.53) per share. This is a 1.92 percent decrease over losses of $(0.52) per share from the same period last year.

雷諾製藥公司(納斯達克代碼:RPHM)公佈季度每股虧損0.53美元。這比去年同期每股虧損0.52美元減少了1.92%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論